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OBJECTIVES: Periodontal disease has been associated with higher circulating levels of inflammatory markers and conditions
associated with chronic inflammation, including vascular disease, diabetes mellitus, and cancer. Limited data exist on the
relationship between periodontal disease and gastric and duodenal ulcer.
METHODS: We conducted a prospective cohort study of 49,120 men in the Health Professionals Follow-up Study, aged 40–75
years at enrollment in 1986. Biennially, we assessed periodontal disease, tooth loss, and other risk factors for gastric and
duodenal ulcer. We validated diagnoses of gastric and duodenal ulcer through medical record review. We used Cox proportional
hazards modeling, adjusting for potential confounders, to estimate hazard ratios (HRs) and 95% confidence intervals (CIs).
RESULTS: We documented 138 cases of gastric ulcer and 124 cases of duodenal ulcer with available information on Helicobacter
pylori status over 24 years of follow-up. After adjustment for risk factors, including smoking and regular use of aspirin and non-
steroidal anti-inflammatory drugs, men with periodontal disease with bone loss had a multivariate HR of ulcer of 1.62 (95% CI,
1.24–2.12). Periodontal disease appeared to be associated with a similar risk of developing ulcers that were H. pylori negative
(HR 1.75; 95% CI, 1.26–2.43) than H. pylori positive (HR 1.40; 95% CI, 0.87-2.24), as well as ulcers in the stomach (HR 1.75; 95% CI,
1.21–2.53) than ulcers in the duodenum (HR 1.47; 95% CI, 0.98–2.19).
CONCLUSIONS: Periodontal disease is associated with an increased risk of incident gastric and duodenal ulcer. This relation-
ship may be mediated by alterations in the oral and gastrointestinal microbiome and/or systemic inflammatory factors.
Clinical and Translational Gastroenterology (2014) 5, e49; doi:10.1038/ctg.2013.14; published online 13 February 2014
Subject Category: Stomach
INTRODUCTION
Periodontal disease is characterized by microbial shifts within
the oral cavity and chronic inflammation of the gingival tissue,
and can lead to tooth loss. Several studies support an
association between periodontal disease and risk of chronic
systemic conditions, including vascular disease, chronic
obstructive pulmonary disease, diabetesmellitus, and cancer,
including gastric adenocarcinoma.1–15 These associations
may be mediated by systemic inflammation, the immune
response to periodontal infection, or direct invasion by patho-
gens. Previous studies of periodontal disease and risk of
peptic ulcer have been limited by cross-sectional design,
diagnoses that were not confirmed by medical record review,
and a lack of information on key confounders, including
smoking, aspirin and non-steroidal anti-inflammatory drug
(NSAID) use, socioeconomic status, and Helicobacter pylori
infection status.16–19
To address these limitations, we investigated the relation-
ship between periodontal disease and the risk of gastric
and duodenal ulcer among men enrolled in the Health
Professionals Follow-up Study (HPFS), a large cohort of US
male health professionals who provided updated data on oral
health and other risk factors, including smoking and aspirin
and NSAID use, over 24 total years of follow-up. This
population is relatively homogenous in terms of socioeco-
nomic and educational status, which minimizes the potential
influence of confounding lifestyle factors.
METHODS
Study population. The HPFS is a prospective cohort of
51,529 US male dentists (58%), veterinarians (20%),
pharmacists (8%), optometrists (7%), osteopathic physicians
(4%), and podiatrists (3%), aged 40–75 years at enrollment,
who returned a mailed health questionnaire in 1986.
Subsequently, biennial questionnaires were returned by
participants with a follow-up rate exceeding 90%. Data on
newly diagnosed medical conditions, including periodontal
disease and peptic ulcer, as well as lifestyle factors, including
smoking and alcohol use, were obtained from follow-up
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questionnaires. The National Death Index was searched for
questionnaire non-respondents with a sensitivity of 98%.20
Assessment of periodontal disease. In the 1986 ques-
tionnaire and every 2 years thereafter, participants were
asked if they had been diagnosed with ‘‘periodontal disease
with bone loss.’’ Participant responses to this question have
been previously validated against dental X-rays of 140
dentists and 212 non-dentists with and without a self-
reported diagnosis of periodontal disease.21,22 Bone loss
was assessed from the radiographs by blinded examiners
and was used as the standard measure of cumulative
periodontal disease. Among dentists, the positive predictive
value was 0.76 and the negative predictive value was 0.74. In
non-dentists, the positive predictive value was 0.80 and the
negative predictive value was 0.68.
In the 1986 questionnaire, participants were asked to
classify their number of natural teeth into one of the following
categories: 0, 1–10, 11–16, 17–24, or 25–32 teeth. Starting in
1988 and every 2 years thereafter, participants also reported
any incident tooth loss over each follow-up period. Self-
reported tooth count has been highly correlated with actual
number of teeth on clinical examination in a general
population cohort (correlation coefficient: 0.97).23
Assessment of smoking history and other risk factors.
In the 1986 questionnaire and every 2 years thereafter,
participants were asked to report information on their smoking
status, regular use of aspirin and NSAIDs, and if they had
been diagnosed with diabetes. Every 4 years, intake of
alcohol was reported as part of a dietary questionnaire.24
Body mass index (kg/m2) was calculated from self-reported
body weight (updated biennially) and height (reported at
baseline in 1986). The accuracy of body measures has been
previously validated within this cohort.25
Ascertainment of outcome. At baseline in 1986, partici-
pants were asked to report any previous history of peptic
ulcer, including the type of ulcer (gastric or duodenal) and an
approximate time of occurrence. Every two years thereafter,
participants were asked to report new diagnoses of gastric or
duodenal ulcer and the year of their diagnosis. Over the 24-
year follow-up period, 2,006 total participants reported an
ulcer diagnosis and were subsequently sent a detailed
supplemental questionnaire and a request for permission to
obtain relevant medical records. On the basis of a more
detailed definition of ulcer on this supplemental question-
naire, 406 (20%) men subsequently denied an ulcer
diagnosis and 280 men (14%) denied permission to review
their medical records. Thus, we requested medical records
for 1,320 men, obtaining records with adequate information
for review for 1,214 men. Two study team members, blinded
to exposure information, independently reviewed and
extracted data from hospital notes, discharge summaries,
endoscopy reports, and pathology reports. Based on
diagnosis by upper endoscopy (84%), barium study (13%),
and/or surgery (3%), we confirmed 934 ulcer cases. For the
46 cases with both a gastric and duodenal ulcer, we
categorized each case according to the location of the
primary ulcer as assessed by ulcer size, number, and/or
stigmata. We further classified ulcers as H. pylori positive or
negative based on available information in the medical record
or if a participant reported a history of previous H. pylori
infection on the 2004 questionnaire. Among 934 confirmed
ulcer cases, we excluded 257 prevalent cases (diagnosed
previous to 1986), 71 cases with ulcers identified by methods
other than endoscopy or surgery or with a primary location
outside the stomach or duodenum, 30 cases with a history of
cancer at baseline, and 34 cases with unknown periodontal
disease status. In addition, we excluded 14 cases with
recurrent history of ulcer disease diagnosed during the
follow-up period. Because of the causal association between
H. pylori infection and ulcer disease, we restricted our
population to participants with available H. pylori data and
therefore excluded an additional 265 cases.
Statistical analysis. After exclusions, there were 49,120
men and 262 incident ulcer cases for our analyses. Person-
time for each participant was calculated from the date of
return of the baseline questionnaire to the date of the first
gastric or duodenal ulcer event, death from any cause, or 1
January 2010, whichever came first. Individuals who
reported an ulcer but for whom we had insufficient records
to confirm the diagnosis or assign H. pylori infection status at
the time of the ulcer event were censored at the time period
in which they reported their ulcer. We used Cox proportional
hazards modeling, using time-varying variables with the most
updated information for periodontal disease and other
covariates before each 2-year interval, to compute hazard
ratios (HRs) and 95% confidence intervals (CIs). We also
tested for statistical heterogeneity within our analyses by
calculating stratum-specific HRs and likelihood-ratios for
other potential ulcer risk factors. All analyses in this study
were performed using SAS version 9.2 (SAS Institute Inc.,
Cary, NC, USA). All P-values were two-sided, and Po0.05
was considered statistically significant.
RESULTS
Among the 49,120 eligible men, we documented 138 incident
cases of gastric ulcer and 124 cases of duodenal ulcer with
available information on H. pylori infection status over
936,931 person-years and 24 calendar years of follow-up.
At baseline, compared with participants who reported no
history of periodontal disease with bone loss, men reporting
this diagnosis were more likely to be older, dentists, diabetic,
self-report as non-white, smoke currently or in the past, have
fewer natural teeth, have a higher body mass index, consume
more alcohol, and regularly use aspirin (Table 1).
Hospitalization was required for 50% of the cases, with 61%
of those hospitalized requiring transfusion and 26% requiring
admission to the intensive care unit. Among the 568 ulcers
diagnosed endoscopically and/or surgically, 72% were clean-
based, 7% had a visible vessel, 7% had an adherent clot, 6%
had active arterial bleeding, 5% had a pigmented or flat spot,
3% were oozing without a clot or visible vessel, and 2% were
perforated. Among the gastric ulcers, 56%were in the antrum,
24%were in the body, 13%were in the pylorus, 4%were in the
fundus, and 3% were in the cardia.
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The absolute risk of gastric or duodenal ulcer among
participants with periodontal disease with bone loss was 0.24
events per 1,000 person-years compared with 0.45 events per
1,000 person-years among participants with no history of
periodontal disease. Men with periodontal disease had an
age-adjusted HR of gastric or duodenal ulcer of 1.66 (95%
CI,1.27–2.16). This association remained significant even
after adjusting for other risk factors, including race, profes-
sion, diabetes, smoking, body mass index, alcohol intake, and
regular use of aspirin and NSAIDs (multivariate-adjusted HR,
1.62; 95% CI, 1.24–2.12) (Table 2).
Periodontal disease appeared to be associated with risk of
both gastric ulcer (multivariate HR, 1.75; 95% CI, 1.21–2.53)
and duodenal ulcer (multivariate HR, 1.47; 95% CI,
0.98–2.19), as well as H. pylori negative (multivariate HR,
1.75; 95% CI, 1.26–2.41) and H. pylori positive (multivariate
HR, 1.40; 95% CI, 0.87–2.24) ulcers (Table 2). Periodontal
disease had a multivariate HR of 1.72 (95% CI, 1.16–2.53)
for ulcer requiring hospitalization, 2.11 (95% CI, 1.28–3.46)
for ulcer requiring transfusion, and 2.06 (95% CI, 0.96–4.41)
for ulcer requiring intensive care unit admission.
We also examined the association between baseline
number of teeth and risk of gastric or duodenal ulcer.
Compared with men who reported 25–32 natural teeth, men
reporting 24 or fewer teeth had an age-adjusted HR of gastric
or duodenal ulcer of 1.44 (95% CI, 1.06–1.96). However, this
association was somewhat attenuated after adjustment for
other risk factors (multivariate-adjusted HR, 1.35; 95% CI,
0.99–1.85). Baseline number of teeth had similar associations
with risk of gastric ulcer (multivariate-adjusted HR, 1.34; 95%
CI, 0.86–2.08) and duodenal ulcer (multivariate-adjusted HR,
1.37; 95% CI, 0.88–2.13) (Table 3).
We also evaluated the association between incident tooth
loss during follow-up and subsequent risk of ulcer. Compared
with men with no tooth loss, men reporting tooth loss during
follow-up had an age-adjusted HR of gastric or duodenal ulcer
of 1.25 (95% CI, 0.95–1.65), which was further attenuated
after adjustment for other risk factors (multivariate-adjusted
HR, 1.07; 95% CI, 0.81–1.42). Tooth loss during follow-up
was not strongly associated with either risk of gastric ulcer
(multivariate-adjusted HR, 1.04; 95% CI, 0.70–1.53) or
duodenal ulcer (multivariate-adjusted HR, 1.11; 95% CI,
0.74–1.67) (Table 3).
We examined the possibility that our observed relationships
were modified by other known or potential risk factors for ulcer.
We did not observe any significant heterogeneity in the
association of periodontal disease with ulcer by subgroups
defined according to bodymass index, smoking, alcohol intake,
regular use of aspirin or NSAIDs, and profession. Most notably,
the effect of periodontal disease persisted among never
Table 1 Age-adjusted baseline characteristics of participants in the Health
Professionals Follow-up Study according to diagnosis of periodontal disease
with bone loss
Periodontal disease with bone loss
No
(N¼ 41,316)
Yes
(N¼7,804)
Mean (s.d.) age, years 53.8 (97) 58.3 (9.2)
Non-white race, % 5 7
Dentist, % 56 67
Diabetic, % 3 5
Number of natural teeth, %
0–24 15 29
25–32 85 71
Body mass index (kg/m2), %
o25 46 43
25.0–29.9 46 48
Z30.0 8 9
Smoking, %
Never 50 30
Past 42 53
Current 9 17
Alcohol intake (g/day), %
0.0 23 21
0.1–4.9 24 23
5.0–14.9 29 29
Z15.0 24 27
Regular user of aspirina, % 29 30
Regular user of NSAIDa, % 5 5
Abbreviation: NSAID, non-steroidal anti-inflammatory drug.
aDefined as intakeZ2 times/week.
Table 2 Risk of gastric or duodenal ulcer according to the diagnosis of
periodontal disease with bone loss
Periodontal disease
with bone loss
No Yes
Gastric and duodenal ulcer
Number of cases/person-years 176/746,133 86/190,798
Age-adjusted (95% CI) 1.00 1.66 (1.27–2.16)
Multivariate-adjusteda (95% CI) 1.00 1.62 (1.24–2.12)
Gastric ulcer
Number of cases/person-years 90/744,014 48/190,196
Age-adjusted (95% CI) 1.00 1.85 (1.29–2.65)
Multivariate-adjusteda (95% CI) 1.00 1.75 (1.21–2.53)
Duodenal ulcer
Number of cases/person-years 86/744,029 38/190,053
Age-adjusted (95% CI) 1.00 1.47 (0.99–2.18)
Multivariate-adjusteda (95% CI) 1.00 1.47 (0.98–2.19)
H. pylori-negative ulcer
Number of cases/person-years 114/746.054 59/190,742
Age-adjusted (95% CI) 1.00 1.75 (1.26–2.41)
Multivariate-adjusteda (95% CI) 1.00 1.75 (1.26–2.43)
H. pylori-positive ulcer
Number of cases/person-years 62/745,946 27/190,720
Age-adjusted (95% CI) 1.00 1.50 (0.94–2.39)
Multivariate-adjusteda (95% CI) 1.00 1.40 (0.87–2.24)
All ulcersb
Number of cases/person-years 401/743,711 149/190,337
Age-adjusted (95% CI) 1.00 1.27 (1.05–1.55)
Multivariate-adjusteda (95% CI) 1.00 1.24 (1.02–1.51)
Abbreviation: CI, confidence interval.
aModels adjusted for age (months), race (white, non-white), profession
(non-dental profession, dentist), diabetes (yes, no), body mass index (o25,
25–29.9,Z30 kg/m2), smoking (never, past, current), alcohol intake (0–4.9, 5–
14.9, Z15 g/day), regular aspirin use (o2, Z2 times/week), and regular non-
steroidal anti-inflammatory drug use (o2,Z2 times/week).
bSensitivity analysis of all ulcer cases, including those with missingH. pylori data.
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smokers (Pheterogeneity¼ 0.13) and individuals who did not
regularly use aspirin or NSAIDs (Pheterogeneity¼ 0.10) (Table 4).
In sensitivity analyses, we conducted a cross-sectional
study evaluating the association between periodontal disease
and prevalent ulcer cases and observed similar association
between periodontal disease and ulcer risk. Compared with
participants without periodontal disease, participants with
periodontal disease had a multivariate-adjusted OR of 1.89
(95%CI, 1.46–2.46) for gastric and duodenal ulcer, 2.06 (95%
CI, 1.45–2.94) for gastric ulcer, and 1.73 (95% CI, 1.18–2.53)
for duodenal ulcer.
DISCUSSION
In this prospective cohort of men, we found that periodontal
disease with bone loss was associated with an increased risk
of gastric and duodenal ulcer. The association appeared
largely consistent for gastric and duodenal ulcers as well as
H. pylori positive and H. pylori negative ulcers. These
Table 3 Risk of gastric or duodenal ulcer according to tooth loss
Number of natural teetha
25–32 0–24
Gastric and duodenal ulcer
Number of cases/person-yearsb 203/787,375 58/141,770
Age-adjusted (95% CI) 1.00 1.44 (1.06–1.96)
Multivariate-adjustedc (95% CI) 1.00 1.35 (0.99–1.85)
Gastric ulcer
Number of cases/person-years 108/785,156 29/141,296
Age-adjusted (95% CI) 1.00 1.46 (0.95–2.25)
Multivariate-adjustedc (95% CI) 1.00 1.34 (0.86–2.08)
Duodenal ulcer
Number of cases/person-years 95/141,183 29/785,122
Age-adjusted (95% CI) 1.00 1.43 (0.93–2.21)
Multivariate-adjustedc (95% CI) 1.00 1.37 (0.88–2.13)
Tooth loss during follow-upd
No Yes
Gastric and duodenal ulcer
Number of cases/person-yearsb 179/662,667 82/194,809
Age-adjusted (95% CI) 1.00 1.25 (0.95–1.65)
Multivariate-adjustedc (95% CI) 1.00 1.07 (0.81–1.42)
Gastric ulcer
Number of cases/person-years 96/660,949 42/194,319
Age-adjusted (95% CI) 1.00 1.25 (0.85–1.83)
Multivariate-adjustedc (95% CI) 1.00 1.04 (0.70–1.53)
Duodenal ulcer
Number of cases/person-years 83/660,793 40/194,278
Age-adjusted (95% CI) 1.00 1.25 (0.84–1.86)
Multivariate-adjustedc (95% CI) 1.00 1.11 (0.74–1.67)
Abbreviation: CI, confidence interval.
aReported by participants on baseline questionnaire in 1986.
bOne case was excluded from both analyses due to missing data on tooth loss
at baseline.
cModels adjusted for age (months), race (white, non-white), profession (non-
dental profession, dentist), diabetes (no, yes), body mass index (o25, 25-29.9,
Z30 kg/m2), smoking (never, past, current), alcohol intake (0–4.9, 5–14.9,
Z15 g/day), regular aspirin use (o2,Z2 times/week) and regular non-steroidal
anti-inflammatory drug use (o2,Z2 times/week).
dUpdated biennially beginning in 1988.
Table 4 Risk of gastric or duodenal ulcer according to diagnosis of periodontal
disease with bone loss, stratified by other risk factors for ulcer
Periodontal disease with bone loss
No Yes
Ageo65 years
Number of cases/person-years 85/458,291 20/82,983
Age-adjusted (95% CI) 1.00 1.21 (0.74–1.99)
Multivariate-adjusteda (95% CI) 1.00 1.14 (0.69–1.89)
AgeZ65 years
Number of cases/person-years 91/287,843 66/107,815
Age-adjusted (95% CI) 1.00 1.93 (1.40–2.65)
Multivariate-adjusteda (95% CI) 1.00 1.92 (1.38–2.67)
Pheterogeneity¼ 0.11
Body mass indexo25 kg/m2
Number of cases/person-years 63/313,633 37/79,011
Age-adjusted (95% CI) 1.00 1.99 (1.30–3.03)
Multivariate-adjusteda (95% CI) 1.00 2.00 (1.29–3.09)
Body mass indexZ25 kg/m2
Number of cases/person-years 113/432,500 49/111,787
Age-adjusted (95% CI) 1.,00 1.51 (1.07–2.14)
Multivariate-adjusteda (95% CI) 1.00 1.43 (1.00–2.03)
Pheterogeneity¼ 0.33
Never smoker
Number of cases/person-years 71/301,651 26/48,477
Age-adjusted (95% CI) 1.00 2.11 (1.31–3.38)
Multivariate-adjusteda (95% CI) 1.00 2.14 (1.32–3.47)
Past/current smoker
Number of cases/person-years 85/277,104 46/96,582
Age-adjusted (95% CI) 1.00 1.36 (0.94–1.97)
Multivariate-adjusteda (95% CI) 1.00 1.34 (0.92–1.95)
Pheterogeneity¼ 0.13
Alcoholo5 g/day
Number of cases/person-years 78/358,995 33/87,310
Age-adjusted (95% CI) 1.00 1.41 (0.93–2.15)
Multivariate-adjusteda (95% CI) 1.00 1.47 (0.95–2.25)
AlcoholZ5 g/day
Number of cases/person-years 98/387,138 53/103,488
Age-adjusted (95% CI) 1.00 1.84 (1.30–2.60)
Multivariate-adjusteda (95% CI) 1.00 1.76 (1.23–2.51)
Pheterogeneity¼ 0.53
Non-regular aspirin or NSAID userb
Number of cases/person-years 47/363,369 30/84,842
Age-adjusted (95% CI) 1.00 2.11 (1.31–3.42)
Multivariate-adjusteda (95% CI) 1.00 2.08 (1.26–3.43)
Regular aspirin or NSAID userb
Number of cases/person-years 129/382,765 56/105,956
Age-adjusted (95% CI) 1.00 1.47 (1.06–2.03)
Multivariate-adjusteda (95% CI) 1.00 1.42 (1.02–1.97)
Pheterogeneity¼ 0.10
Non-dental profession
Number of cases/person-years 86/325,252 38/70,615
Age-adjusted (95% CI) 1.00 1.73 (1.16–2.58)
Multivariate-adjusteda (95% CI) 1.00 1.69 (1.12–2.54)
Dental profession
Number of cases/person-years 90/420,881 48/120,183
Age-adjusted (95% CI) 1.00 1.72 (1.20–2.48)
Multivariate-adjusteda (95% CI) 1.00 1.66 (1.14–2.41)
Pheterogeneity¼ 0.74
Abbreviations: CI, confidence interval; NSAID, non-steroidal anti-inflammatory
drug.
aModels adjusted for age (months), race (white, non-white), profession (non-
dental profession, dentist), diabetes (no, yes), bodymass index (o25, 25–29.9,
Z30 kg/m2), smoking (never, past, current), alcohol intake (0–4.9, 5–14.9,
Z15 g/day), regular aspirin use (o2,Z2 times/week), and regular NSAID use
(o2,Z2 times/week). For each stratified analysis, the variable for the strata of
interest was omitted.
bNon-regular aspirin or NSAID user was defined as intake of aspirin or NSAIDs
o2 times/week. Regular aspirin or NSAID user was defined as intake of aspirin
or NSAIDsZ2 times/week.
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observed associations persisted even after adjusting for
putative risk factors, including smoking, alcohol intake, and
regular use of aspirin and NSAIDs.
Our results are largely consistent with previous studies. In a
recent cross-sectional analysis of 28,765 Japanese insurance
workers, self-reported peptic ulcer was associated with a
history of periodontitis, loss of five or more teeth, and a 1-point
increase in a periodontal risk score.16 Similarly, severe
alveolar bone loss was associated with self-reported ‘‘sto-
mach ulcers’’ in 2,006 patients undergoing dental radiograph
and chart review.17 In a Polish case-control study of 186
H. pylori-infected subjects in which NSAID-associated ulcers
were excluded, various measures of oral health and tooth
decay, but not tooth loss, were associated with ulcer.18 A
cross-sectional study of 603 subjects who underwent oral
examination found that increased clinical attachment loss, but
not missing teeth, gingival recession, or probing depth, was
associated with peptic ulcers.19 Our study significantly
extends these results by using prospective assessments of
periodontal disease before the diagnosis of ulcer, minimizing
the likelihood of recall bias that may have influenced these
previous cross-sectional analyses.16–19 Moreover, these
previous studies relied on self-reported periodontal health
measures16 and ulcer outcomes16,17,19 and were unable to
account for key confounding factors, including NSAID
use,16,17,19 socioeconomic status,16–19 and smoking.18
Periodontal disease has been associated with chronic
systemic inflammation. Previous studies have shown sig-
nificantly higher levels of plasma C-reactive protein among
subjects with periodontal disease,10,26,27 including men in this
cohort.1 In addition, within this cohort, periodontal disease has
been associated with risks of conditions associated with
chronic inflammation, including cardiovascular disease,
ischemic stroke, and cancers of the lung, kidney, and
pancreas.1–5 Thus, it is possible that periodontal disease
may be associated with a systemic inflammatory response
that predisposes to ulcer risk.
Periodontal disease is also known to be associated with
shifts in oral microbiota, and this may affect the integrity of
gastrointestinal mucosa. In previous studies, individuals with
periodontal disease and tooth loss have exhibited increased
oral and gastric populations of H. pylori, a well-established
cause of peptic ulcer.28–33 Adding periodontal treatment to
standard triple antibiotic therapy also increased the effective-
ness of gastric H. pylori eradication in studies of a general
population cohort and of patients with chronic gastric
illness.34–35 However, periodontal disease’s association with
gastric and duodenal ulcer may be related to mechanisms
other than H. pylori colonization, as our data showed similar
associations between periodontal disease and risk of
H. pylori-positive and H. pylori-negative ulcers. One hypoth-
esis is that oral microbiota, which have been associated with
the impaired healing of periodontal lesions,36–39 may also be a
source of chronic inflammation and impaired wound healing of
gastrointestinal tract mucosa.
Our analyses of both natural teeth at baseline and tooth loss
during follow-up and risk of gastric and duodenal ulcer were
generally in agreement with our findings for periodontal
disease. However, these associations were weaker and also
attenuated with multivariate adjustment. Tooth loss reflects
both periodontal disease and other factors, including caries,
trauma, cosmetic procedures, use of bisphosphonates, and
access to dental care. Hence, tooth loss, especially at later
ages, could be used as a marker of periodontal disease but
needs to be interpreted more cautiously.
The strengths of our study include a relatively large number
of incident cases of gastric and duodenal ulcer, detailed and
updated information on periodontal disease and ulcer diag-
noses for420 years of follow-up, and extensive and detailed
information on potential confounders, particularly smoking,
alcohol intake, and use of aspirin and NSAIDs. Because our
cohort is comprised of health professionals, confounding by
education, socioeconomic status, and inaccurate reporting of
periodontal disease and incident ulcer was minimized.
There are several limitations of our study that deserve
mention. First, data on periodontal disease was self-reported,
which may affect the reliability of our results. However,
previous examination of periodontal disease within the HPFS
has shown self-reporting within this cohort to have high
positive and negative predictive value among both non-
dentists and dentists.21,22 In addition, the risk of ulcer
associated with periodontal disease was not modified
according to dental vs. non-dental profession in our stratified
analysis. Second, our study population consists of predomi-
nantly white, US, male health professionals, which may limit
the generalizability of our findings to other populations.
Furthermore, although our cohort is occupationally homo-
genous, we acknowledge the possibility that residual differ-
ence in the socioeconomic status of participants (such as in
early childhood) may have influenced our results. Third, we
could not confirm all cases of self-reported ulcer and our data
on H. pylori infection status was incomplete. However, to
minimize bias, we censored such men from our analyses and
used self-reported H. pylori infection data to classify a portion
of the unknown data. Furthermore, sensitivity analyses that
included all confirmed ulcer cases, irrespective of the
availability of data on H. pylori status, showed similar risk
estimates to our main analyses, which included only cases
with available H. pylori data (see Table 2, All ulcers). Fourth,
our findings might not be generalizable to less severe forms of
ulcer cases that do not require hospitalization, endoscopy, or
imaging. Finally, our study is observational, and we cannot
rule out the possibility of residual confounding. However,
residual confounding by some of the strongest risk factors for
ulcer disease, such as smoking or aspirin/NSAID use is
unlikely, as we observed consistent results within strata of
never smokers and non-users of aspirin/NSAIDs.
In conclusion, our study showed that periodontal disease
and tooth loss were associated with an increased risk of
gastric and duodenal ulcer. These findings provide additional
support for a potential association between chronic inflamma-
tion, oral microbiota dissemination, and gastrointestinal
ulceration. Further study is needed to determine whether
practices that promote periodontal health may help reduce
risk of peptic ulcer disease.
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mechanisms that underlie this association.
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